[The discovery of haloperidol].

Area of Science:

• Pharmacology
• Psychiatry
• Medicinal Chemistry

Background:

• Haloperidol (R1625), a butyrophenone derivative, was synthesized in 1958.
• Early animal pharmacology indicated superior potency compared to chlorpromazine.
• Initial human studies focused on agitation states.

Discussion:

• Haloperidol confirmed as a neuroleptic, effective against delusions and hallucinations.
• Clinical studies validated its therapeutic potential in psychiatric disorders.
• Significant impact on reducing chronic inpatient populations.

Key Insights:

• High potency of haloperidol at low doses.
• Broad efficacy in treating positive psychotic symptoms.
• Facilitated community reintegration for psychiatric patients.

Outlook:

• Haloperidol remains a widely prescribed neuroleptic decades after its introduction.
• Continued relevance in managing chronic mental health conditions.
• Foundation for further neuroleptic drug development.